EZH2 expression was low in three samples (<1.5% of positive tumor cells), intermediate in one sample (1.5% ≤ x ≤ 3% positive tumor cells), and high (>3% of positive tumor cells) in the two remaining cases (Figure S4). This evidence concerns the gene EZH2 and neoplasm.